Section Arrow
Quote
GKOS.NYSE
- Glaukos Corp
Quotes are at least 15-min delayed:2025/04/29 23:56 EDT
Last
 93.83
+0.02 (+0.02%)
Day High 
94.72 
Prev. Close
93.81 
1-M High
100.565 
Volume 
915.49K 
Bid
75.03
Ask
95.25
Day Low
92.82 
Open
94.05 
1-M Low
77.91 
Market Cap 
5.36B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 92.31 
20-SMA 91.54 
50-SMA 105.06 
52-W High 163.71 
52-W Low 77.91 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
-2.77/0.02
Enterprise Value
5.46B
Balance Sheet
Book Value Per Share
13.43
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
383.48M
Operating Revenue Per Share
5.32
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
BSXBoston Scientific Corp102.74+0.56+0.55%82.3PE
PACBPacific Biosciences of California1.11-0.02-1.77%-- 
MDTMedtronic plc84.6+0.56+0.67%25.62PE
EWEdwards Lifesciences Corp76.28+0.74+0.98%32.28PE
ABTAbbott Laboratories130.5+0.97+0.75%16.95PE
Quotes are at least 15-min delayed：2025/04/29 23:56 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.